JAVIER GARCÍA CORBACHO – ENSAYO CLÍNICO CON MEDICAMENTOS – GENENTECH INC
A PHASE Ia/Ib, OPEN LABEL, MULTICENTER, DOSE-ESCALATION STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF RO7502175 AS A SINGLE AGENT AND IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
by prodriguez | Jul 3, 2024 | Clinical Trials, Ensayos Clínicos - CIMO-01 | 0 comments